TINZAPARIN

26th July, 2024 Health

TINZAPARIN

Source: IndianExpress

Disclaimer: Copyright infringement not intended.

Context

A recent study published in Science Translational Medicinesuggests that tinzaparin, a drug typically used to prevent blood clots, might significantly reduce the damage caused by cobra venom.
The researchers are planning to start human clinical trials soon.

Details

Key Findings

Venom Characteristics and Impact:
- The study focused on the venom of the red spitting cobra (Naja pallida) and the black-necked spitting cobra.
- The venom of these cobras attacks cells in the body and damages the nervous system, leading to severe pain and potential disability if not fatal.
Current Challenges with Antivenoms:
- Traditional antivenoms are produced by injecting small amounts of venom into animals to generate antibodies, which are then extracted and administered to snakebite victims.
- These antivenoms are expensive, difficult to produce, store, and transport, and can cause severe side effects.
Tinzaparin's Mechanism:
- The study found that tinzaparin reduces the damage caused by cobra venom by interfering with the biological pathway responsible for synthesizing heparan sulfate.
- Heparan sulfate plays a role in blood vessel and clot formation, and the venom's toxicity relies on this pathway. Tinzaparin mimics heparan sulfate, thus blocking the venom's interaction with human cells.
Research Methodology:
- Researchers used CRISPR-Cas9 technology to knock out specific genes in human cells to understand how venom affects them.
- They discovered that genes involved in heparan sulfate synthesis were crucial for the venom's toxic effects.
- Tinzaparin was introduced to the cells after venom exposure, significantly improving cell survival.

Tinzaparin

Tinzaparin is a low molecular weight heparin (LMWH) primarily used as an anticoagulant to prevent and treat deep vein thrombosis (DVT) and pulmonary embolism (PE).
It is especially used post-surgery to prevent clot formation when patients are immobile.
Tinzaparin works by inhibiting factor Xa and thrombin in the coagulation pathway, thereby preventing the formation of blood clots.
This action is similar to other anticoagulants in the heparin group, but its lower molecular weight allows for more predictable pharmacokinetics and dynamics.

Types Of Toxins, Their Effects, And Their Applications In Biomedicine

*Category*	*Description*	*Examples of Venom Components*	*Effects*	*Biomedical Applications*
Neurotoxins	Target and disrupt nervous system functions by blocking or modulating neurotransmitter receptors and ion channels.	α-neurotoxins, β-neurotoxins, dendrotoxins, PLA2s	Paralysis, respiratory failure, neurodegeneration.	Pain management, neurodegenerative disease research, potential treatments for epilepsy and stroke.
Cardiotoxins	Affect heart muscle function, leading to heart failure or other cardiac issues.	Cobra cardiotoxin, taipoxin	Arrhythmias, heart failure, myocardial damage.	Cardiovascular disease research, development of new heart medications.
Hemotoxins	Disrupt blood coagulation processes, causing excessive bleeding or clotting.	Metalloproteinases, serine proteinases, C-type lectins	Hemorrhage, thrombosis, tissue necrosis.	Anticoagulant drug development, treatment for blood clotting disorders.
Cytotoxins	Destroy cells by targeting cell membranes, leading to cell lysis and death.	L-amino acid oxidases, myotoxins	Tissue damage, necrosis, inflammation.	Cancer research (targeting cancer cells), antimicrobial and antiviral therapies.
Myotoxins	Target and damage muscle tissues, leading to muscle necrosis.	Myotoxin a, crotamine	Muscle pain, weakness, paralysis.	Muscular disease research, development of muscle relaxants and treatments for muscle-related injuries.
Nephrotoxins	Affect kidney function, potentially leading to renal failure.	Viper venom components	Acute kidney injury, renal failure.	Kidney disease research, development of nephroprotective drugs.
Anti-coagulants	Prevent blood from clotting, leading to excessive bleeding.	Disintegrins, anticoagulant peptides	Bleeding disorders, impaired wound healing.	Development of anticoagulant medications for conditions like deep vein thrombosis and pulmonary embolism.
Pro-coagulants	Promote blood clotting, which can lead to thrombosis.	Thrombin-like enzymes, fibrinogenases	Thrombosis, embolism.	Research on clotting disorders, development of clot-dissolving drugs.
Vasculotoxins	Damage blood vessels, leading to hemorrhage and tissue damage.	Vascular endothelial growth factors (VEGFs)	Hemorrhage, edema, tissue necrosis.	Development of treatments for vascular diseases, study of blood vessel growth and repair mechanisms.
Anti-inflammatory	Components that modulate inflammatory responses.	Snake venom metalloproteinases (SVMPs)	Reduction of inflammation, immune modulation.	Development of anti-inflammatory drugs for conditions like arthritis and other inflammatory diseases.
Antibacterial/Antibiotic	Compounds with antimicrobial properties that can kill or inhibit the growth of bacteria.	Cathelicidins, phospholipase A2	Inhibition of bacterial growth, potential treatment of bacterial infections.	Development of new antibiotics, treatment for antibiotic-resistant bacterial infections.
Antifungal	Components that can inhibit the growth of fungi.	Lectins, defensins	Inhibition of fungal growth, potential treatment of fungal infections.	Development of antifungal medications.
Antiviral	Components that can inhibit the replication of viruses.	L-amino acid oxidase, phospholipase A2	Inhibition of viral replication, potential treatment of viral infections.	Development of antiviral drugs, research on viral mechanisms and host interactions.
Analgesic	Compounds that can reduce pain.	Bradykinin potentiating peptides (BPPs), mambalgins	Pain relief, potential treatments for chronic pain conditions.	Development of new analgesics for pain management.

About Cobra

*Category*	*Details*
General Characteristics	Cobras are a group of highly venomous snakes known for their ability to flare their neck ribs to form a hood when threatened. They belong to the Elapidae family and are primarily found in Africa and Asia. Cobras have a varied diet, primarily consisting of small mammals, birds, reptiles, and amphibians. IUCN Status: Least Concern
Key Species	Indian (Spectacled) Cobra (Naja naja): Found in South Asia, it has distinctive spectacle-like markings on its hood. Venom is neurotoxic, affecting the nervous system. Grows up to 6 feet in length and primarily diurnal. Protected by law in some countries due to habitat loss and poaching. Egyptian Cobra (Naja haje): Found in North Africa, this species prefers warm climates and exhibits diurnal or nocturnal behavior based on temperature. Feeds on small mammals, birds, and reptiles. Known for its powerful neurotoxic venom and effective hood display as a defense mechanism. ·Cape Cobra (Naja nivea): Native to Southern Africa, recognized for its potent neurotoxic venom. Exhibits varied coloration and impressive speed. Primarily found in grasslands and savannas. Notably adaptive to different environments and exhibits sexual dimorphism with females being larger. Red Spitting Cobra (Naja pallida): Native to Africa, capable of spitting venom up to 8 feet. Primarily nocturnal and preys on rodents and small mammals. Venom contains potent neurotoxins. Black Spitting Cobra (Naja nigricollis):Found across Africa, known for its sleek black coloration and venom-spitting ability. Feeds on small mammals, birds, and other reptiles. Venom includes neurotoxins and cytotoxins, causing paralysis and tissue damage.
Venom Composition	Cobra venom typically contains neurotoxins, cytotoxins, and cardiotoxins. These toxins affect the nervous system, cause tissue damage, and can lead to respiratory failure or cardiac arrest. The exact composition and potency vary among species.
Behavior	Cobras are generally solitary, coming together only during mating seasons. They exhibit territorial and defensive behaviors, such as hood flaring, hissing, and striking. While some species are diurnal, others may shift to nocturnal activity in extremely hot climates. Most cobras rely on body language and chemical signals for communication.
Reproduction	Cobras are oviparous, laying eggs in secluded locations. Clutch sizes vary, but typically range from 8 to 20 eggs. The incubation period is about 60 to 80 days, depending on environmental conditions. Hatchlings are independent from birth.
Ecological Role	Cobras play a crucial role in controlling rodent populations and maintaining ecological balance. They are apex predators in their habitats and have few natural enemies once they reach adulthood. Some cultures also revere them for their symbolic significance.